190 related articles for article (PubMed ID: 24020493)
1. Cause-specific telomere factors deregulation in hepatocellular carcinoma.
El Idrissi M; Hervieu V; Merle P; Mortreux F; Wattel E
J Exp Clin Cancer Res; 2013 Sep; 32(1):64. PubMed ID: 24020493
[TBL] [Abstract][Full Text] [Related]
2. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract][Full Text] [Related]
3. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
4. Telomere biology and telomerase mutations in cirrhotic patients with hepatocellular carcinoma.
Donaires FS; Scatena NF; Alves-Paiva RM; Podlevsky JD; Logeswaran D; Santana BA; Teixeira AC; Chen JJ; Calado RT; Martinelli ALC
PLoS One; 2017; 12(8):e0183287. PubMed ID: 28813500
[TBL] [Abstract][Full Text] [Related]
5. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of PinX1 in human hepatocellular carcinoma.
Oh BK; Chae KJ; Park C; Park YN
Oncol Rep; 2004 Oct; 12(4):861-6. PubMed ID: 15375513
[TBL] [Abstract][Full Text] [Related]
7. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma.
Cardin R; Piciocchi M; Sinigaglia A; Lavezzo E; Bortolami M; Kotsafti A; Cillo U; Zanus G; Mescoli C; Rugge M; Farinati F
BMC Cancer; 2012 May; 12():177. PubMed ID: 22587342
[TBL] [Abstract][Full Text] [Related]
8. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Miura N; Horikawa I; Nishimoto A; Ohmura H; Ito H; Hirohashi S; Shay JW; Oshimura M
Cancer Genet Cytogenet; 1997 Jan; 93(1):56-62. PubMed ID: 9062581
[TBL] [Abstract][Full Text] [Related]
9. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Hepatocellular Carcinoma in Cirrhotic Patients with Chronic Hepatitis B.
Zhang YQ; Peng LJ; Cao YR; Zeng ZP; Wu YJ; Shi H; Cheng SY; Wang JY; Friedman SL; Sninsky JJ; Guo JS
Genet Test Mol Biomarkers; 2016 Sep; 20(9):535-43. PubMed ID: 27391584
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of hepatocarcinogenesis.
Sheu JC
J Gastroenterol Hepatol; 1997 Oct; 12(9-10):S309-13. PubMed ID: 9407351
[TBL] [Abstract][Full Text] [Related]
12. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
[TBL] [Abstract][Full Text] [Related]
14. High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis.
Oh BK; Kim H; Park YN; Yoo JE; Choi J; Kim KS; Lee JJ; Park C
Lab Invest; 2008 Feb; 88(2):144-52. PubMed ID: 18158557
[TBL] [Abstract][Full Text] [Related]
15. Telomere length variation in tumor cells and cancer-associated fibroblasts: potential biomarker for hepatocellular carcinoma.
Ma LJ; Wang XY; Duan M; Liu LZ; Shi JY; Dong LQ; Yang LX; Wang ZC; Ding ZB; Ke AW; Cao Y; Zhang XM; Zhou J; Fan J; Gao Q
J Pathol; 2017 Dec; 243(4):407-417. PubMed ID: 28833123
[TBL] [Abstract][Full Text] [Related]
16. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis.
Lee YH; Oh BK; Yoo JE; Yoon SM; Choi J; Kim KS; Park YN
Mod Pathol; 2009 Aug; 22(8):1121-31. PubMed ID: 19465904
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pathways associated with hepatitis B- and C-infected hepatocellular carcinoma using pathway-based class discrimination method.
Lee SY; Song KH; Koo I; Lee KH; Suh KS; Kim BY
Genomics; 2012 Jun; 99(6):347-54. PubMed ID: 22564472
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Uridine⁻Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients-A Pilot Study.
Buivydiene A; Liakina V; Kashuba E; Norkuniene J; Jokubauskiene S; Gineikiene E; Valantinas J
Medicina (Kaunas); 2018 Sep; 54(5):. PubMed ID: 30344298
[No Abstract] [Full Text] [Related]
20. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
Lee JE; Oh BK; Choi J; Park YN
Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
